<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000554353"><TermName>Torisel</TermName><TermPronunciation>(TOR-ih-sel)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Torisel blocks a protein involved in cell division, and may kill cancer cells. It is a type of rapamycin analog and a type of serine/threonine kinase inhibitor. Also called CCI-779 and temsirolimus.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718587" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Torisel&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718586" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Torisel&quot;" language="es" id="_4"/><SpanishTermName>Torisel</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el carcinoma de células renales (un tipo de cáncer de riñón) en estadio avanzado. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. Torisel bloquea una proteína que participa en la multiplicación celular y puede destruir células cancerosas. Es un tipo de análogo de la rapamicina y un tipo de inhibidor de la cinasa de serina/treonina. También se llama CCI-779 y temsirolimús.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-06-08</DateFirstPublished><DateLastModified>2008-03-13</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000553445">Temsirolimus</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
